The effects of metabolic parameters of aripiprazole in patients with schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 27 Feb 2017 Last checked against ClinicalTrials.gov record.
- 17 Jun 2009 Planned end date changed from 1 Sep 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
- 14 Jul 2008 Status changed from in progress to recruiting as reported by ClinicalTrials.gov.